One-Half of Low-Risk PC Patients Transition From Active Surveillance to Active Treatment According to a study in the Journal of Urology, within a few years after diagnosis, an estimated 50% of men who were initially managed with active surveillance for "low-risk" prostate cancer (PC) shift to definitive treatment, such as surgery or radiation therapy. Read more.
|
PARP Inhibitor Maintenance Therapy Expanding in Recurrent Ovarian Cancer The use of maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer has been confirmed in several clinical trials, but a recent study in Gynecologic Oncology explored the real-world treatment patterns for this type of cancer. Read more.
|